Stock Screener App

Frei -

Installieren

16.54

0.47% -0.075

Viatris Inc (VTRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Viatris Inc Aktie (VTRS) Neueste Nachrichten

Leerink Partners Initiates Viatris at Outperform With $20 Price Target - marketscreener.com

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating - Moomoo

Viatris gets 11% passive stake disclosed by FMR | VTRS SEC FilingForm SCHEDULE 13G/A - Stock Titan

Argus Research Upgrades Viatris(VTRS.US) to Buy Rating, Announces Target Price $20 - Moomoo

Viatris Inc. (VTRS) Stock Analysis: Evaluating the Healthcare Giant’s 9.60% Potential Upside for Investors - DirectorsTalk Interviews

Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune

Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune

Viatris (VTRS) Q2 2026 Earnings Call Transcript - Fortune

Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch

Viatris Inc. stock rises Monday, outperforms market - MarketWatch

Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris - Yahoo Finance

Viatris Inc. (VTRS) Stock Analysis: Exploring Its 13% Upside Potential And Dividend Appeal - DirectorsTalk Interviews

Viatris (VTRS) Faces Fresh Generic Earnings Questions, Is The 12% Discount Enough? - Yahoo Finance

Viatris Inc (VTRS) Shares Fall 3.3% -- GF Value Says Still Overv - GuruFocus

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Viatris Inc (VTRS): A Closer Look Behind a 60 GF Score - GuruFocus

Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch

Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.36% Potential Upside Amidst Mixed Financial Signals - DirectorsTalk Interviews

Viatris' China Policy Concerns Overstated, UBS Says - Moomoo

Barclays Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $22 - Moomoo

Viatris Inc. (VTRS) Stock Analysis: Healthcare Giant with a 13.99% Upside and Strategic Collaborations - DirectorsTalk Interviews

5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call - Yahoo Finance

Viatris Inc. stock rises Friday, outperforms market - MarketWatch

Viatris Inc (VTRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com

Viatris Inc. (VTRS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine? - Yahoo Finance

Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch

Davis Selected Advisers (VTRS) discloses 75.2M-share, 6.5% stake in Viatris Inc - Stock Titan

ETFs Investing in Viatris, Inc. Stocks - TradingView

TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - TradingView

Harrow adds TYRVAYA's global rights to dry eye portfolio - Glance by Eyes On Eyecare

Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run - Sahm

Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash - TradingView

Viatris Inc. (VTRS) Stock Analysis: Unveiling a 12.6% Potential Upside Amidst Strong Cash Flow - DirectorsTalk Interviews

Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback - simplywall.st

Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program - finance.yahoo.com

Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval - Yahoo Finance

Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress - Yahoo Finance

Viatris Inc. (VTRS) Stock Forecasts - Yahoo! Finance Canada

Viatris (VTRS) Raises 2026 Guidance, Is The 11% Gap Below Fair Value Enough? - Yahoo Finance

Viatris (VTRS) Stock Looks Stuck Between Higher Guidance And Wider Losses - Sahm

Viatris Inc. (US92556V1061.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada

Viatris Inc. Stock Sheds 7.7%, Underperforms Market - webull.com

Viatris Earnings: Good Performance in Key Regions and Outlook Increase Make for a Solid Quarter - Morningstar

Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc. - VisionMonday.com

Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside - TradingView

Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ... - Yahoo Finance

Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overv - GuruFocus

Viatris Inc. stock falls Thursday, underperforms market - MarketWatch

Viatris Inc Q2 2026: Revenue $3.76B, EPS $(0.10) — 10-Q Summary - TradingView

Viatris (NASDAQ: VTRS) swings to H1 2026 profit as revenue tops $7.27B - Stock Titan

Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022. - marketscreener.com

Viatris Q2 2026 slides: strong beat, raised outlook, H2 headwinds - Investing.com

Viatris Q2 2026 slides: strong results lift guidance amid H2 headwinds - Investing.com

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook - TradingView

Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth - Morningstar

Viatris Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:VTRS) 2026-08-06 - Seeking Alpha

Viatris stock hits 52-week high at 18.27 USD - Investing.com

Viatris Q2 2026 slides: strong beat drives guidance raise - Investing.com

FMR LLC discloses 8.3% Viatris Inc (VTRS) ownership, over 96M shares - Stock Titan

Earnings call transcript: Viatris tops Q2 2026 estimates, lifts outlook - Investing.com

Viatris Announces Quarterly Dividend - marketscreener.com

Viatris Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Viatris Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

VIATRIS INC (VTRS.VI) Q2 FY2026 earnings call transcript - Yahoo Finance

Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

UTHR

$503.10

0.86%

NBIX

$153.69

0.90%

ELAN

$23.77

0.81%

RDY

$11.84

0.32%

ALKS

$45.35

0.22%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters